XML 22 R8.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Total Shareholders' Equity
Common Stock
APIC
AOCI
Retained Earnings
NCI
Beginning Balance (in shares) at Dec. 31, 2023     170        
Beginning balance at Dec. 31, 2023 $ 2,052 $ 1,940 $ 2 $ 1,228 $ (269) $ 979 $ 112
Increase (Decrease) in Shareholders' Equity              
Net earnings (loss) 40 59       59 (19)
OCI (50) (50)     (50)    
Contributions (Distributions) to NCI, net (2)           (2)
Other NCI transactions 5 3   3     2
Stock-based plan activity (in shares)     1        
Stock-based plan activity (1) (1)   (1)      
Ending Balance (in shares) at Mar. 31, 2024     171        
Ending balance at Mar. 31, 2024 2,044 1,951 $ 2 1,230 (319) 1,038 93
Beginning Balance (in shares) at Dec. 31, 2023     170        
Beginning balance at Dec. 31, 2023 2,052 1,940 $ 2 1,228 (269) 979 112
Increase (Decrease) in Shareholders' Equity              
Net earnings (loss) 194            
OCI (58)            
Ending Balance (in shares) at Jun. 30, 2024     171        
Ending balance at Jun. 30, 2024 2,243 2,142 $ 2 1,262 (329) 1,207 101
Beginning Balance (in shares) at Mar. 31, 2024     171        
Beginning balance at Mar. 31, 2024 2,044 1,951 $ 2 1,230 (319) 1,038 93
Increase (Decrease) in Shareholders' Equity              
Net earnings (loss) 153 169       169 (16)
OCI (8) (10)     (10)   2
Contributions (Distributions) to NCI, net 22           22
Other NCI transactions 23 23   23      
Stock-based plan activity 9 9   9      
Ending Balance (in shares) at Jun. 30, 2024     171        
Ending balance at Jun. 30, 2024 2,243 2,142 $ 2 1,262 (329) 1,207 101
Beginning Balance (in shares) at Dec. 31, 2024     169        
Beginning balance at Dec. 31, 2024 3,992 3,949 $ 2 1,174 (351) 3,124 43
Increase (Decrease) in Shareholders' Equity              
Net earnings (loss) (232) (241)       (241) 9
OCI 26 26     26    
Contributions (Distributions) to NCI, net 8           8
Other NCI transactions (1)           (1)
Stock-based plan activity (in shares)     1        
Stock-based plan activity 1 1   1      
Repurchase of common stock (in shares)     (4)        
Repurchase of common stock (144) (144)   (144)   0  
Ending Balance (in shares) at Mar. 31, 2025     166        
Ending balance at Mar. 31, 2025 3,650 3,591 $ 2 1,031 (325) 2,883 59
Beginning Balance (in shares) at Dec. 31, 2024     169        
Beginning balance at Dec. 31, 2024 3,992 3,949 $ 2 1,174 (351) 3,124 43
Increase (Decrease) in Shareholders' Equity              
Net earnings (loss) 2,206            
OCI 72            
Ending Balance (in shares) at Jun. 30, 2025     162        
Ending balance at Jun. 30, 2025 5,978 5,949 $ 2 887 (279) 5,339 29
Beginning Balance (in shares) at Mar. 31, 2025     166        
Beginning balance at Mar. 31, 2025 3,650 3,591 $ 2 1,031 (325) 2,883 59
Increase (Decrease) in Shareholders' Equity              
Net earnings (loss) 2,438 2,460       2,460 (22)
OCI 46 46     46   0
Contributions (Distributions) to NCI, net (8)           (8)
Other NCI transactions 0            
Stock-based plan activity 9 9   9      
Repurchase of common stock (in shares)     (4)        
Repurchase of common stock (157) (157)   (153)   (4)  
Ending Balance (in shares) at Jun. 30, 2025     162        
Ending balance at Jun. 30, 2025 $ 5,978 $ 5,949 $ 2 $ 887 $ (279) $ 5,339 $ 29